Immunogenicity Issues in the Development of Therapeutic Proteins

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.21, Iss.3, 2007-01, pp. : 207-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Immunogenicity Relationships of Therapeutic Proteins

By Hermeling Suzanne Crommelin Daan J. A. Schellekens Huub Jiskoot Wim

Pharmaceutical Research, Vol. 21, Iss. 6, 2004-06 ,pp. : 897-903

Springer Publishing Company

Access to resources Recommend Favorite

Immunogenicity Assessment of Therapeutic Proteins and Peptides

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 4, 2009-06 ,pp. : 352-358

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation Development for Hydrophobic Therapeutic Proteins

By Hawe Andrea Frieß Wolfgang

Pharmaceutical Development and Technology, Vol. 12, Iss. 3, 2007-05 ,pp. : 223-237

Informa Healthcare

Access to resources Recommend Favorite

Product development issues for PEGylated proteins

By Payne Robert W. Murphy Brian M. Manning Mark Cornell

Pharmaceutical Development and Technology, Vol. 16, Iss. 5, 2011-10 ,pp. : 423-440

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins

By Mahmood Iftekhar Green Martin D.

Clinical Pharmacokinetics, Vol. 44, Iss. 4, 2005-01 ,pp. : 331-347

Adis International

Access to resources Recommend Favorite